/ LLY
/ Market Analysis
Eli Lilly Breaks $1 Trillion Barrier, a First for the Healthcare Industry
Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as demand for its weight-loss drugs ...
November 21, 2025
Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance.
October 30, 2025
Why LLY Shares Are Sliding in Premarket Trading: Trump’s Remarks Shake Sector
Eli Lilly shares fell over 3% in premarket trading after Trump signaled price cuts for weight loss drugs, sparking concerns over future margins.
October 17, 2025
Why are Eli Lilly’s Shares Crashing Today Despite Strong Earnings?
Eli Lilly's stock crashed over 14% despite strong Q2 earnings, as disappointing weight-loss pill trial results overshadowed 38% revenue growth and raised guidance.
August 07, 2025
Why are Verve Therapeutics Shares Skyrocketing in Premarket Trading Today?
Eli Lilly is reportedly close to acquiring gene editing partner Verve Therapeutics for up to $1.3 billion.
June 17, 2025More from The Tokenist / LLY
Eli Lilly’s Q4 2024 Revenue Surges by 45% to $13.53 Billion
February 06, 2025
LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs
November 20, 2024
Stocks to Watch Today: Tesla, LLY, and Bank of America
August 20, 2024
Back to 
